Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
51
Number of overlapping holdings
15.8%
% of FHLC's 349 holdings also in WDNA
60.7%
% of WDNA's 90 holdings also in FHLC
Overlap by Weight
Sector Drift (FHLC minus WDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FHLC |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 11.3% | 2.7% | 2.7% |
|
GILEAD SCIENCES INC | 2.3% | 1.9% | 1.9% |
|
VERTEX PHARMACEUTICALS INC | 2.0% | 1.8% | 1.8% |
|
AMGEN INC | 2.8% | 1.7% | 1.7% |
|
BRISTOL-MYERS SQUIBB CO | 2.0% | 1.5% | 1.5% |
Position Highlights (Non-Overlapping Exposures)
FHLC Overweight Relative to WDNA
|
ELI LILLY & CO | 8.6% |
|
UNITEDHEALTH GROUP INC | 7.3% |
|
ABBVIE INC | 6.1% |
|
JOHNSON & JOHNSON | 5.0% |
|
ABBOTT LABORATORIES | 3.8% |
|
INTUITIVE SURGICAL INC | 3.0% |
|
MERCK & CO. INC. | 2.7% |
|
BOSTON SCIENTIFIC CORP | 2.3% |
|
STRYKER CORP | 2.1% |
|
THERMO FISHER SCIENTIFIC INC | 2.0% |
FHLC Underweight Relative to WDNA
|
NATERA INC | -3.4% |
|
TWIST BIOSCIENCE CORP. | -3.2% |
 |
NOVOZYMES A/S-B SHARES | -2.9% |
|
VERICEL CORPORATION | -2.5% |
|
BLUEPRINT MEDICINES CORP. | -2.5% |
|
BRIDGEBIO PHARMA, INC. | -2.3% |
|
VERACYTE INC | -2.0% |
|
AGIOS PHARMACEUTICALS INC | -1.9% |
 |
NOVARTIS AG | -1.7% |
|
UNITED THERAPEUTICS CORP | -1.5% |